UAE Wound Care Management Devices - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)

The uAE wound care management devices market size is expected to grow from USD 91.94 million in 2025 to USD 97.02 million in 2026 and is forecast to reach USD 126.91 million by 2031 at 5.52% CAGR over 2026-2031. This report is Segmented by Product (Advanced Wound Management Products[Advanced Wound Dressings and More] and Surgical Wound-Care Products), Wound Type (Chronic Wounds and Acute Wounds), End User (Hospitals & Specialty Wound Clinics and More), and Mode of Purchase (Institutional Procurement and Retail / OTC Channel). The Market and Forecasts are Provided in Terms of Value (USD).

UAE Wound Care Management Devices Market Trends and Insights

Rising Incidence of Chronic Wounds Drives Market Expansion

High diabetes prevalence underpins a steady rise in diabetic foot ulcers, while plantar-pressure studies recording 911 kPa peak forces link gait mechanics to ulcer risk. Multidrug-resistant organisms complicate care, with methicillin-resistant Staphylococcus aureus rates reaching 25-35% across GCC hospitals. In response, the Ministry of Health and Prevention introduced 4D bioprinting to create patient-specific grafts for diabetic wounds, reinforcing the UAE wound care management devices market’s technology leadership. Nursing staff - 63,366 professionals across 19,102 beds - now follow enhanced pressure-injury protocols that improve outcomes in acute and home settings. Collectively, these factors lift demand for advanced dressings, antimicrobial gels, and remote-monitoring solutions.

Growth in Surgical & Trauma Procedures Spurs Product Uptake

A national network of hospitals delivers rising volumes of orthopedic, cardiovascular, and bariatric surgeries that require specialized closure materials and infection prevention systems. Dubai’s emergency department KPI framework mandates time-bound wound management, steering hospitals toward faster-acting tissue adhesives and negative-pressure wound therapy devices. Medical tourists add further volume, as facilities such as American Hospital Dubai promote complex surgical packages across 30 overseas offices. Surgical growth, therefore, catalyzes the uptake of antimicrobial sutures, collagen dressings, and post-operative compression systems.

Cost Barriers Limit Advanced Technology Adoption

Premium hydrofiber dressings, negative-pressure pumps, and hyperbaric chambers raise procurement budgets at smaller clinics, especially in the Northern Emirates with tighter funding envelopes. Storage and cold-chain requirements inflate operating costs during 45 °C summer peaks, prompting selective roll-outs and reliance on bulk tenders in Dubai and Abu Dhabi. Providers, therefore, weigh clinical gains against pay-out ratios when adopting next-generation modalities such as growth-factor gels and bioengineered skin substitutes.

Other drivers and restraints analyzed in the detailed report include:

• Ageing Expatriate Demographics Elevate Long-Term Care Needs
• Federal Investments Under Dubai Health Strategy Accelerate Technology Adoption
• Reimbursement Limitations Restrict Outpatient Care Access

Segment Analysis

Advanced Wound Management Products accounted for 64.10% of the UAE wound care management devices market in 2025, reflecting strong demand for alginate, hydrocolloid, and antimicrobial foam dressings used in chronic and post-surgical settings. Deployment of 4D-bioprinted grafts for diabetic foot ulcers underscores hospitals’ preference for regenerative therapies that shorten healing cycles. Surgical Wound-Care Products, though smaller, are set to advance at a 6.28% CAGR as laparoscopic and orthopedic volumes climb, driving sales of absorbable sutures, tissue sealants, and hemostatic patches.

Local manufacturing moves - such as Ayu Life Sciences’ AED 33 million factory in Jebel Ali - promise import substitution, potentially stabilizing prices and insulating hospitals from supply-chain shocks. The UAE wound care management devices industry continues to prize products that integrate moisture control, antimicrobial action, and data capture for KPI reporting.

Chronic wounds represented 60.85% of the UAE wound care management devices market share in 2025, driven by diabetic foot ulcers, venous leg ulcers, and pressure injuries common among older expatriates. Hospitals invest in collagen matrices, silver alginates, and compression systems that address biofilm challenges and venous insufficiency.

Acute wounds are projected to expand faster, at a 6.63% CAGR, supported by rising surgical throughput and trauma services that require rapid-closure adhesives and advanced hemostats. As the UAE wound care management devices market size for acute wound supplies grows, vendors highlight ease-of-use kits suited to emergency settings where DHA KPIs specify strict door-to-closure timelines. The UAE wound care management devices industry, therefore, balances chronic protocols with trauma-ready products across its multi-tier health system.

Complete Report Scope:

• By Product
  • Advanced Wound Management Products
    • Advanced Wound Dressings
      • Foam Dressings
      • Hydrocolloid Dressings
      • Film Dressings
      • Alginate Dressings
      • Hydrogel Dressings
      • Other Advanced Dressings
    • Wound Therapy Devices
      • Pressure-relief Devices
      • Negative Pressure Wound Therapy (NPWT) Systems
      • Oxygen & Hyperbaric Oxygen Equipment
      • Electrical Stimulation Devices
      • Other Therapy Devices
  • Surgical Wound-Care Products
    • Sutures & Staples
    • Tissue Adhesives / Sealants / Glues
• By Wound Type
  • Chronic Wounds
    • Diabetic Foot Ulcers
    • Venous Leg Ulcers
    • Pressure Ulcers
  • Acute Wounds
    • Surgical / Traumatic Wounds
    • Burns
• By End-User
  • Hospitals & Specialty Wound Clinics
  • Long-term Care Facilities
  • Home-Healthcare Settings
• By Mode of Purchase
  • Institutional Procurement
  • Retail / OTC Channel

List of Companies Covered in this Report:

• Johnson & Johnson
• Solventum
• Smiths Group
• ConvaTec Group plc
• Medtronic
• Beiersdorf
• Coloplast
• Molnlycke Health Care
• Urgo Medical
• Essity
• Hartmann Group
• Hollister
• Medline Industries
• Integra LifeSciences
• Organogenesis Holdings
• Kerecis ehf
• DeRoyal Industries
• HidraMed Solutions
• Pharmaplast

Additional Benefits:

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support